Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matti L Gild

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Archives of Osteoporosis|June 12, 2026
Risk stratification improves outcomes in an osteoporosis fracture liaison serviceShejil Kumar, Lillias Nairn, Angela Bowman, et al.
Endocrine Oncology (Bristol, England)|June 25, 2025
Real-world lenvatinib use in metastatic thyroid cancer: early dose intensity and side effect profile in an Australian centreMonica Majumder, Shejil Kumar, Tony Lian, et al.
Clinical Endocrinology|May 10, 2018
Role of DOTATATE-PET/CT in preoperative assessment of phaeochromocytoma and paragangliomasMatti L Gild, Nikita Naik, Jeremy Hoang, et al.
Clinical Endocrinology|November 3, 2017
Clinical guidance for radioiodine refractory differentiated thyroid cancerMatti L Gild, Duncan J Topliss, Diana Learoyd, et al.
Thyroid : Official Journal of the American Thyroid Association|April 2, 2019
RET Kinase-Regulated MicroRNA-153-3p Improves Therapeutic Efficacy in Medullary Thyroid CarcinomaLauren Jin Suk Joo, Jocelyn Weiss, Anthony J Gill, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 16, 2023
The Clinical Utility of Gallium-68-DOTATATE Positron Emission Tomography Scanning in Medullary Thyroid CancerMatti L Gild, Shejil Kumar, Talia L Fuchs, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2023
Homozygous Ser-1 to Pro-1 mutation in parathyroid hormone identified in hypocalcemic patients results in secretion of a biologically inactive pro-hormonePatrick Hanna, Ashok Khatri, Shawn Choi, et al.
The American Journal of Surgical Pathology|May 27, 2020
A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative NecrosisTalia L Fuchs, Anthony J Nassour, Anthony Glover, et al.
Pathology|January 29, 2026
Atypical morphological features in secondary and tertiary hyperparathyroidism mimic malignancy: a detailed clinicopathological studyÏa Robert-Montaner, Amy Sheen, Loretta Sioson, et al.
Asia-Pacific Journal of Clinical Oncology|August 15, 2024
Anaplastic thyroid cancer: A review of recent evidence and summary of an Australian institutional protocolAnna K Lawless, Shejil Kumar, Jessica Bindra, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Archives of Osteoporosis|June 12, 2026
Risk stratification improves outcomes in an osteoporosis fracture liaison serviceShejil Kumar, Lillias Nairn, Angela Bowman, et al.
Endocrine Oncology (Bristol, England)|June 25, 2025
Real-world lenvatinib use in metastatic thyroid cancer: early dose intensity and side effect profile in an Australian centreMonica Majumder, Shejil Kumar, Tony Lian, et al.
Clinical Endocrinology|May 10, 2018
Role of DOTATATE-PET/CT in preoperative assessment of phaeochromocytoma and paragangliomasMatti L Gild, Nikita Naik, Jeremy Hoang, et al.
Clinical Endocrinology|November 3, 2017
Clinical guidance for radioiodine refractory differentiated thyroid cancerMatti L Gild, Duncan J Topliss, Diana Learoyd, et al.
Thyroid : Official Journal of the American Thyroid Association|April 2, 2019
RET Kinase-Regulated MicroRNA-153-3p Improves Therapeutic Efficacy in Medullary Thyroid CarcinomaLauren Jin Suk Joo, Jocelyn Weiss, Anthony J Gill, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 16, 2023
The Clinical Utility of Gallium-68-DOTATATE Positron Emission Tomography Scanning in Medullary Thyroid CancerMatti L Gild, Shejil Kumar, Talia L Fuchs, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2023
Homozygous Ser-1 to Pro-1 mutation in parathyroid hormone identified in hypocalcemic patients results in secretion of a biologically inactive pro-hormonePatrick Hanna, Ashok Khatri, Shawn Choi, et al.
The American Journal of Surgical Pathology|May 27, 2020
A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative NecrosisTalia L Fuchs, Anthony J Nassour, Anthony Glover, et al.
Pathology|January 29, 2026
Atypical morphological features in secondary and tertiary hyperparathyroidism mimic malignancy: a detailed clinicopathological studyÏa Robert-Montaner, Amy Sheen, Loretta Sioson, et al.
Asia-Pacific Journal of Clinical Oncology|August 15, 2024
Anaplastic thyroid cancer: A review of recent evidence and summary of an Australian institutional protocolAnna K Lawless, Shejil Kumar, Jessica Bindra, et al.
Pageof 5